WHO seeks more data from Merck and Bharat Biotech

WHO assistant director said that the organisation expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine -- Covaxin -- and will meet on November 3 for a final risk-benefit assessment for the Emergency Use Listing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vSsVKZ
via IFTTT